Suggestions
Andrew Wardle
Biotech Investor in New York
Andrew Wardle is a prominent figure in the biotech investment sector, currently serving as a Principal at Venrock in New York since September 2021. He has a diverse background that combines medicine and business, having earned an MBA from Stanford Graduate School of Business. His career includes significant roles in various healthcare and biotech companies, including as a co-founder of Halo Biosciences and involvement in Mirum Pharmaceuticals and Frazier Healthcare Partners.135
Wardle's medical background includes experience as a physician at Imperial College Healthcare NHS Trust and as a research fellow at Great Ormond Street Hospital for Children. He has received several accolades, including the Medical Student of the Year award from The Royal College of Paediatrics and Child Health.13
In addition to his investment work, Wardle has been active in the startup ecosystem, contributing to projects focused on pulmonary hypertension and other medical innovations.24